Wednesday, March 17, 2010

DHL Further Strengthen Clinical Trials Logistics Service

Number of Specialist Depots Doubled
Shipping News Feature

WORLDWIDE – Global freight and logistics giant DHL has further strengthened its position as a leading global Clinical Trials Logistics provider by doubling the number of its global depots from 8 to 16 to include India, China, Panama, Canada, USA, Chile, Argentina and Lebanon.

DHL now offers its Clinical Trials Logistics (CTL) service across 64 countries worldwide. This expansion enables DHL to service additional key research sites around the world with special focus upon the new supply sources that are emerging for this sector around the world.

Chris Tierney, Director of the Clinical Trials Logistics service at DHL Supply Chain, said: "Clinical research is becoming increasingly global and so is the demand for clinical trials logistics. Over the last four years, we have met this challenge by doubling our depot network while providing a consistent quality of standards, processes, capabilities and pricing. We are confident that we can play a key role in the further globalization of clinical trials to help accelerate the discovery of new and groundbreaking treatments."

According to DHL the doubling of the number of clinical trial depots they have increased their capacity to support global clinical research projects, including so-called "mega-trials" in the pharmaceutical and vaccine industries.

By combining their global presence and transport infrastructure, the company state that their CTL teams combines knowledge of import laws, regulatory insight and local expertise to “design customized health care supply chains.”